Skip to content
PubMed This is a summary of 11 peer-reviewed journal articles Updated
Medical Genetics · Autosomal Dominant Optic Atrophy

Can Autosomal Dominant Optic Atrophy Skip a Generation?

At a Glance

Genetically, Autosomal Dominant Optic Atrophy (ADOA) does not skip a generation, as there is a 50% chance of passing the mutated OPA1 gene to a child. However, it can appear to skip generations because some people inherit the gene but never develop noticeable vision loss.

Autosomal Dominant Optic Atrophy (ADOA) does not truly “skip” a generation genetically, but it can certainly look like it does. Because of how the disease affects different people, a parent might pass the mutated gene to their child, but that child could have symptoms so mild that they never realize they have the condition [1][2]. When that child grows up and has a baby who develops obvious vision loss, it appears as though the disease skipped a generation.

The 50% Chance: Autosomal Dominant Inheritance

ADOA is an inherited genetic condition. Most cases of classic ADOA are caused by a mutation in a gene called OPA1 [3]. Everyone has two copies of the OPA1 gene, but in ADOA, one copy is mutated. The term autosomal dominant describes how this mutated gene is passed from parent to child:

  • Autosomal means the gene is not tied to sex chromosomes, so men and women are equally likely to inherit and pass on the condition.
  • Dominant means that a child only needs to inherit one copy of the mutated gene from one parent to have the condition [4].

Because you have ADOA, there is a 50% chance with each pregnancy that you will pass the mutated gene to your child, and a 50% chance that you will pass on the healthy gene [5]. If your child inherits your healthy gene, they will not have ADOA and cannot pass it on to their future children.

Why It Looks Like It Skips: Variable Expressivity and Incomplete Penetrance

If a child does inherit the mutated OPA1 gene, it is very difficult to predict how severely their vision will be affected. Importantly, your symptom severity does not predict your child’s severity—if you have mild vision loss, your child could still experience severe vision loss, or vice versa [6]. Genetic counselors use two key concepts to explain this:

Variable Expressivity

Variable expressivity means that people with the exact same genetic mutation can experience vastly different symptoms [6]. Within the same family, one person might experience severe vision loss starting in early childhood, while another might only have very mild vision issues that are barely noticeable [2]. In some cases, factors like birth weight, gestational age, and lifestyle habits that stress the mitochondria—such as smoking and excessive alcohol use—may influence how severely the disease expresses itself [7][8].

Incomplete Penetrance

Incomplete penetrance refers to the fact that some people who carry the genetic mutation for ADOA never develop any symptoms of the disease at all during their lifetime [1][9]. They are completely asymptomatic.

Because of variable expressivity and incomplete penetrance, the mutated gene can quietly pass through a generation [6][10]. If your child inherits the gene but has no symptoms, they might go their whole life thinking they don’t have ADOA. However, they would still have a 50% chance of passing the gene to their own children, who might then experience much more severe vision loss [5].

Looking Forward: Family Planning and Child Monitoring

If you are planning to have children, it can be stressful thinking about the 50% inheritance risk. It is highly recommended to speak with a genetic counselor. They can discuss proactive family planning options, such as in vitro fertilization (IVF) combined with preimplantation genetic testing (PGT-M), which allows doctors to screen embryos for the OPA1 mutation before pregnancy.

If you already have children, genetic testing can confirm if they have inherited the OPA1 mutation, even if they have no obvious vision problems [11]. If they carry the mutation, or if you choose not to test them genetically, they should have routine eye exams with an ophthalmologist or neuro-ophthalmologist. Standard eye exams may miss the subtle signs of ADOA, so specialized imaging of the optic nerve is necessary to track any early changes in their vision over time.

Common questions in this guide

Can Autosomal Dominant Optic Atrophy skip a generation?
Genetically, the condition does not skip a generation. However, because some people who carry the mutated gene never develop obvious symptoms, it can appear as though the disease skipped them when they pass it on to a child who later develops vision loss.
What is the chance of passing ADOA to my child?
Because ADOA is an autosomal dominant condition, there is a 50 percent chance with each pregnancy that you will pass the mutated OPA1 gene to your child. If they inherit the healthy gene, they will not have the condition and cannot pass it on.
Will my child's ADOA symptoms be as severe as mine?
Not necessarily. ADOA has variable expressivity, meaning that people with the exact same genetic mutation can have vastly different symptoms. Your level of vision loss does not predict how severe your child's symptoms might be.
Are there ways to prevent passing ADOA to my future children?
If you are planning to have children, you can speak with a genetic counselor about in vitro fertilization (IVF) combined with preimplantation genetic testing (PGT-M). This advanced option allows doctors to screen embryos for the OPA1 mutation before pregnancy.
Should my child see an eye doctor if they have no symptoms?
Yes, even if your child shows no obvious vision problems, a neuro-ophthalmologist can perform specialized imaging tests like Optical Coherence Tomography (OCT). This helps track early, subtle changes in the optic nerve that standard eye exams might miss.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.What proactive family planning options, such as IVF with PGT-M, are available to help prevent passing the ADOA mutation to my future children?
  2. 2.At what age should I start bringing my child to a neuro-ophthalmologist for baseline testing, even if they do not show symptoms?
  3. 3.What specific imaging tests, like Optical Coherence Tomography (OCT), do you recommend to monitor my child's optic nerve?
  4. 4.Are there specific lifestyle factors, medications, or environmental exposures my child should avoid to help protect their mitochondrial function and remaining vision?
  5. 5.Can you refer me to a genetic counselor to discuss my family's specific genetic mutation and how it might affect our care?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (11)
  1. 1

    [Genetic Causes and Genetic Diagnostic Testing of Inherited Optic Atrophies].

    Wissinger B

    Klinische Monatsblatter fur Augenheilkunde 2018; (235(11)):1235-1241 doi:10.1055/a-0759-2094.

    PMID: 30458563
  2. 2

    A Perspective on Accelerated Aging Caused by the Genetic Deficiency of the Metabolic Protein, OPA1.

    Erchova I, Sun S, Votruba M

    Frontiers in neurology 2021; (12()):641259 doi:10.3389/fneur.2021.641259.

    PMID: 33927681
  3. 3

    Optical coherence tomography angiography in the multimodal assessment of the retinal posterior pole in autosomal dominant optic atrophy.

    Cesareo M, Giannini C, Di Marino M, et al.

    Acta ophthalmologica 2022; (100(3)):e798-e806 doi:10.1111/aos.14972.

    PMID: 34250739
  4. 4

    ATPase Domain AFG3L2 Mutations Alter OPA1 Processing and Cause Optic Neuropathy.

    Caporali L, Magri S, Legati A, et al.

    Annals of neurology 2020; (88(1)):18-32 doi:10.1002/ana.25723.

    PMID: 32219868
  5. 5

    Dominant Optic Atrophy (DOA): Modeling the Kaleidoscopic Roles of OPA1 in Mitochondrial Homeostasis.

    Del Dotto V, Carelli V

    Frontiers in neurology 2021; (12()):681326 doi:10.3389/fneur.2021.681326.

    PMID: 34177786
  6. 6

    A novel OPA1 mutation causing variable age of onset autosomal dominant optic atrophy plus in an Australian family.

    Ahmad KE, Davis RL, Sue CM

    Journal of neurology 2015; (262(10)):2323-8 doi:10.1007/s00415-015-7849-6.

    PMID: 26194196
  7. 7

    Visual Function and Inner Retinal Structure in Relation to Birth Factors in Autosomal Dominant Optic Atrophy.

    Eckmann-Hansen C, Bek T, Sander B, Larsen M

    Investigative ophthalmology & visual science 2023; (64(10)):32 doi:10.1167/iovs.64.10.32.

    PMID: 37498569
  8. 8

    A Missense Mutation in OPA1 Causes Dominant Optic Atrophy in a Chinese Family.

    Mei S, Huang X, Cheng L, et al.

    Journal of ophthalmology 2019; (2019()):1424928 doi:10.1155/2019/1424928.

    PMID: 31781369
  9. 9

    Genetic background modulates phenotypic expressivity in OPA1 mutated mice, relevance to DOA pathogenesis.

    Atamena D, Gurram V, Petsophonsakul P, et al.

    Frontiers in molecular neuroscience 2023; (16()):1241222 doi:10.3389/fnmol.2023.1241222.

    PMID: 37736113
  10. 10

    Genotype-phenotype and OCT correlations in Autosomal Dominant Optic Atrophy related to OPA1 gene mutations: Report of 13 Italian families.

    Pretegiani E, Rosini F, Rufa A, et al.

    Journal of the neurological sciences 2017; (382()):29-35 doi:10.1016/j.jns.2017.09.018.

    PMID: 29111013
  11. 11

    Exome sequencing identified a novel de novo OPA1 mutation in a consanguineous family presenting with optic atrophy.

    Cohen L, Tzur S, Goldenberg-Cohen N, et al.

    Genetics research 2016; (98()):e10 doi:10.1017/S0016672316000070.

    PMID: 27265430

This page explains the genetic inheritance of ADOA for educational purposes only. Always consult a genetic counselor or neuro-ophthalmologist for personalized advice regarding family planning and specific genetic risks.

Get notified when new evidence is published on Autosomal dominant optic atrophy, classic form.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.